Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 56 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 9187413

    Peripherally restricted FAAH inhibitors

    The Regents of the University of California · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted
  2. US 9187497

    Substituted pyrido[3,2-e]pyrrolo[1,2-a]pyrazines as inhibitors of poly(ADP-ribose)polymerase (PARP)

    Takeda Pharmaceutical Company Limited · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted
  3. US 9186362

    Methods involving aldose reductase inhibitors

    The Board of Regents of the University of Texas System · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted
  4. US 9181255

    Fused heteroaromatic pyrrolidinones as SYK inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted
  5. US 9180122

    5- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain

    Takeda Pharmaceutical Company Limited · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted
  6. US 9181222

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted
  7. US 9173882

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted
  8. US 9169249

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted
  9. US 9168269

    Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-virals

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted
  10. US 9163022

    Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

    VTV THERAPEUTICS LLC · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  11. US 9163235

    Inhibitors of the miR-15 family of micro-RNAs

    MIRAGEN THERAPEUTICS, INC. · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  12. US 9156818

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  13. US 9156820

    Polycyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  14. US 9149475

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  15. US 9149489

    Inhibitors of glycolysis useful in the treatment of brain tumors

    The Board of Regents of the University of Texas System · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  16. US 9149479

    Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

    TAKEDA GMBH · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  17. US 9150588

    Substituted pyridazin-4(1H)-ones as phosphodiesterase 10A inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  18. US 9150500

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  19. TW 201536770

    Urea compounds and their use as enzyme inhibitors

    BIAL PORTELA & CA SA [PT] · Granted Oct 1, 2015 · Expires Sep 26, 2035

    granted
  20. US 9145433

    GDF-8 inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted
  21. US 9137973

    Pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted
  22. US 9138437

    Pyrimidine substituted purine compounds as kinase (S) inhibitors

    VERASTEM, INC. · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted
  23. US 9132174

    Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)

    Anchored RSK3 Inhibitors, LLC · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted
  24. US 9133200

    Imidazo[1,2-b]pyridazine and imidazo[4,5-b]pyridine derivatives as JAK inhibitors

    Almirall, S.A. · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted